Category Archives: OSP

Federal Agency Updates – NIH and NSF

Agency updates are provided to keep you apprised of what’s happening with some of our major federal sponsors. Many of these updates impact investigators directly. National Institutes of Health (NIH) NIH is rolling out new forms and data management and sharing policies effective January 25, 2023. Look for specific I/Cs to issue guidance on data […]

Posted in OSP | Tagged , , , , , , , , , , , , , | Comments closed

NIH Closeout Procedures (From the PI Perspective)

Now that you are nearing the end of your NIH project do you know how to properly close out the award? When you accept an NIH grant you are agreeing to the terms and conditions included in your Notice of Award.  The terms include the NIH policy requiring submission of three types of final reports […]

Also posted in RGC | Tagged , , , , , , , , , | Comments closed

OSP Update: GA Department of Public Health Indirect Cost Rate Policy

The Georgia Department of Public Health has confirmed that the recovery of indirect costs is capped at 11.5%.  To the extent federal funding is involved, we may collect indirect costs in accordance with our federally negotiated rate agreement, unless the federal agency has imposed limitations on F&A recovery.  Accordingly, any budget routed to OSP and […]

Posted in OSP | Tagged , , , , | Comments closed

FY22 Fringe Rate Announcement

*Sent on behalf of the Office of Sponsored Programs & Research Grants and Contracts* Dear Colleagues, The FY22 federal and non-federal fringe rates have now been approved. The new rates are as follows: These fringe rates become effective on September 1, 2021. All proposals to federal sponsors (or for federal flow-through) should begin using the […]

Also posted in Controller's Office, RGC | Tagged , , , , , , , , | Comments closed

Change in F&A Rate for Clinical Trials Effective 4/1/2021

The below message was sent on behalf of Dr. Robert Nobles, Vice President for Research Administration: March 12, 2021 Dear Colleagues, I am writing to share the outcome of an extensive review of our clinical trial definition and Facilities and Administrative Rate (F&A) rate. Over several months, we organized a working group that included faculty, […]

Also posted in ORA, RGC | Tagged , , , , , , , | Comments closed

Updated Guidance on Biosketch/Other Support Implementation

*Catch up on the Thursdays at Three (T@3) webinar addressing changes to the NIH Biosketch and Other Support here May 7, 2021 Dear Colleagues, We are writing to provide you the most up-to-date information on the transition to new formats for NIH Biosketches and Other Support pages. According to the most recent issue of the […]

Also posted in ORA, RAS | Tagged , , , , , , | Comments closed

ORA Contract Leadership Announcement

The Emory Office of Research Administration (ORA) is pleased to announce the appointment of Janette Hannam Hayes as Interim Director of Contracts, Office of Sponsored Programs (OSP) as of April 1, 2021.  Janette has served OSP for over 23 years.  In that time, Ms. Hannam Hayes has provided leadership in various roles such as Senior […]

Also posted in Announcements, ORA | Tagged , , , , , | Comments closed

NIH Application Policy- Quick Reminder on Hyperlinks

Hyperlinks! They’re not everywhere you want them to be! OSP would like to issue a quick reminder regarding the inclusion of hyperlinks in NIH proposals as we have seen a number of applications come to us which include hyperlinks where they shouldn’t be included. While we have not yet seen an application rejected for this […]

Posted in OSP | Tagged , , , , , | Comments closed

Update to Fringe Rates for FY21

In July 2020, the Fringe Rates for FY21 were posted to the Emory Finance website.  This information was shared in the July ORA Newsletter article here. As of 1/1/2021, Ways & Means has decided to lower the non-federal physician fringe rate from 17.4% to 17.0%.  All other rates remain unchanged for the rest of FY21. […]

Also posted in Controller's Office, RGC | Tagged , , , , , , , | Comments closed

Rapid Response Expedites COVID-19 Related Studies at Emory

In January 2020, the Georgia CTSA Quality & Efficiency program finalized their SOP for the Rapid Response Team to obtain fast-track approvals across the Emory system. This new SOP allows for the coordination of needed approvals within 48 hours. The process was a collaboration, with Office for Clinical Research (OCR) leading Emory’s Rapid Response Team […]

Also posted in OCR, ORA, RAS | Tagged , , , , , , , , , , | Comments closed